Hologic, Inc.
HOLXNASDAQHealthcare
$76.01
+$0.00(+0.00%)
Market Cap$17.0B
P/E Ratio—
52W High$76.07
52W Low$51.9
Hologic, Inc. (HOLX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HOLX · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Jan 29, 2026EPS Actual
$1.04
Est. $1.09 · -4.6%
Revenue
$1.05B
Est. $1.07B · -2.2%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Jan 29, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
HOLX reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 7, 2026 | $1.09 | — | — | — | $1.03B | — |
| ▼ Q1 FY2026 | Jan 29, 2026 | $1.09 | $1.04 | -4.6% | $1.05B | $1.07B | -2.2% |
| ▲ Q4 FY2025 | Nov 3, 2025 | $1.10 | $1.13 | +2.7% | $1.05B | $1.03B | +1.5% |
| ▲ Q3 FY2025 | Jul 30, 2025 | $1.05 | $1.08 | +2.9% | $1.02B | $1.03B | -1.0% |
| — Q2 FY2025 | May 1, 2025 | $1.02 | $1.03 | +1.0% | $1.01B | $1.00B | +0.5% |
| — Q1 FY2025 | Feb 5, 2025 | $1.02 | $1.03 | +1.0% | $1.02B | $1.02B | -0.1% |
| — Q4 FY2024 | Nov 4, 2024 | $1.01 | $1.01 | +0.0% | $0.99B | $0.98B | +1.0% |
| ▲ Q3 FY2024 | Jul 29, 2024 | $1.02 | $1.06 | +3.9% | $1.01B | $1.00B | +1.0% |
Q2 FY2026
May 7, 2026
EPS Actual
—
EPS Est.
$1.09
EPS Surpr.
—
Revenue
—
Q1 FY2026
Jan 29, 2026Miss
EPS Actual
$1.04
EPS Est.
$1.09
EPS Surpr.
-4.6%
Revenue
$1.05B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
$1.13
EPS Est.
$1.10
EPS Surpr.
+2.7%
Revenue
$1.05B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$1.08
EPS Est.
$1.05
EPS Surpr.
+2.9%
Revenue
$1.02B
Q2 FY2025
May 1, 2025
EPS Actual
$1.03
EPS Est.
$1.02
EPS Surpr.
+1.0%
Revenue
$1.01B
Q1 FY2025
Feb 5, 2025
EPS Actual
$1.03
EPS Est.
$1.02
EPS Surpr.
+1.0%
Revenue
$1.02B
Q4 FY2024
Nov 4, 2024
EPS Actual
$1.01
EPS Est.
$1.01
EPS Surpr.
+0.0%
Revenue
$0.99B
Q3 FY2024
Jul 29, 2024Beat
EPS Actual
$1.06
EPS Est.
$1.02
EPS Surpr.
+3.9%
Revenue
$1.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $1.36 | $1.38 | $1.41 | 7 |
| Q2 FY2028 | $1.26 | $1.28 | $1.30 | 4 |
| Q1 FY2028 | $1.23 | $1.25 | $1.27 | 7 |
| Q4 FY2027 | $1.22 | $1.24 | $1.26 | 3 |
| Q3 FY2027 | $1.28 | $1.30 | $1.32 | 6 |
| Q2 FY2027 | $1.20 | $1.22 | $1.24 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $1.1B | $1.2B | $1.2B | 2 |
| Q2 FY2028 | $1.1B | $1.1B | $1.2B | 2 |
| Q1 FY2028 | $1.1B | $1.1B | $1.1B | 2 |
| Q4 FY2027 | $1.1B | $1.1B | $1.1B | 5 |
| Q3 FY2027 | $1.1B | $1.1B | $1.1B | 5 |
| Q2 FY2027 | $1.1B | $1.1B | $1.1B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Jan 29, 2026 | -4.6% | $75.10 | $74.98 | -0.16% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +2.7% | $73.91 | $74.06 | +0.20% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +2.9% | $66.04 | $64.98 | -1.61% |
| ▲ Q2 FY2025 | May 1, 2025 | +1.0% | $58.20 | $57.28 | -1.58% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +1.0% | $71.58 | $72.80 | +1.70% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +0.0% | $82.33 | $83.72 | +1.69% |
| ▲ Q3 FY2024 | Jul 29, 2024 | +3.9% | $78.63 | $79.64 | +1.28% |
| ▲ Q2 FY2024 | May 2, 2024 | +5.3% | $76.28 | $75.91 | -0.49% |
Q1 FY2026-0.16%
Report Date
Jan 29, 2026
EPS Beat/Miss
-4.6%
Price Before
$75.10
Price After
$74.98
Q4 FY2025+0.20%
Report Date
Nov 3, 2025
EPS Beat/Miss
+2.7%
Price Before
$73.91
Price After
$74.06
Q3 FY2025-1.61%
Report Date
Jul 30, 2025
EPS Beat/Miss
+2.9%
Price Before
$66.04
Price After
$64.98
Q2 FY2025-1.58%
Report Date
May 1, 2025
EPS Beat/Miss
+1.0%
Price Before
$58.20
Price After
$57.28
Q1 FY2025+1.70%
Report Date
Feb 5, 2025
EPS Beat/Miss
+1.0%
Price Before
$71.58
Price After
$72.80
Q4 FY2024+1.69%
Report Date
Nov 4, 2024
EPS Beat/Miss
+0.0%
Price Before
$82.33
Price After
$83.72
Q3 FY2024+1.28%
Report Date
Jul 29, 2024
EPS Beat/Miss
+3.9%
Price Before
$78.63
Price After
$79.64
Q2 FY2024-0.49%
Report Date
May 2, 2024
EPS Beat/Miss
+5.3%
Price Before
$76.28
Price After
$75.91
Avg Beat Reaction+0.17%
Avg Miss Reaction-0.16%
Beat Rate7 / 8 quarters
Largest Move+1.70% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HOLX ends December
Hologic, Inc. (HOLX) most recently reported earnings on January 29, 2026 for Q1 FY2026, posting EPS of $1.04 — missing the analyst consensus of $1.09 by -4.6%. The next HOLX earnings date is expected around September 1, 2026.
Each quarter, investors track HOLX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HOLX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HOLX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HOLX earnings · 5 questionsHologic, Inc.'s next earnings report is expected around September 1, 2026. HOLX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HOLX historically reports after market close (AMC).
HOLX earnings datewhen is HOLX earningsHOLX next earnings datewhen does HOLX report earningsHOLX earnings calendar
▸ Source: FMP · Hologic, Inc. SEC filings · US GAAP · Hologic, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026